MedPath

Coronary artery grafting in high risk patients randomised to off-pump or on-pump surgery

Completed
Conditions
Coronary heart disease
Circulatory System
Chronic ischaemic heart disease
Registration Number
ISRCTN29161170
Lead Sponsor
niversity of Oxford (UK)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
5420
Inclusion Criteria

Current information as of 05/03/2010:
Patients having isolated CABG surgery will be eligible if they satisfy the following criteria:
1. Euroscore =5
2. Non-emergency surgery
3. Operation to be carried out via a median sternotomy
4. Written informed patient consent

Initial information at time of registration:
Patients having isolated CABG surgery will be eligible if they satisfy the following criteria:
1. Patients (male or female) aged greater than or equal to 70 years
2. Male patients under 70 years of age with moderate or poor left ventricular function (ejection fraction less than 50%)
3. Euroscore greater than or equal to 5
4. Non-emergency surgery
5. Operation to be carried out via a median sternotomy
6. Written informed patient consent

Exclusion Criteria

Current information as of 05/03/2010:
1. Euroscore <5
2. Emergency operation (immediate revascularisation for haemodynamic instability)
3. Concomitant cardiac procedure with CABG
4. Operation to be carried out via an incision other than a median sternotomy (e.g. anterolateral left thoracotomy)
5. Known contraindication to ONCABG or OPCABG (e.g. calcified aorta, calcified coronaries, small target vessels)

Initial information at time of registration:
1. Male patient under 70 years of age with good left ventricular function (ejection fraction greater than 50%)
2. Euroscore less than 5
3. Emergency operation (immediate revascularisation for haemodynamic instability)
4. Concomitant cardiac procedure with CABG
5. Operation to be carried out via an incision other than a median sternotomy (e.g. anterolateral left thoracotomy)
6. Contraindication to ONCABG or OPCABG (e.g. calcified aorta, intramuscular left anterior descending [LAD], calcified coronaries, small target vessels)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath